Skip to main content
Integrity IndexIntegrity Index
← Companies
CDTX

Cidara Therapeutics, Inc.

Data as of Sep 17, 2026
CDTX
CIK 1610618Biological Products, (No Diagnostic Substances)
Federal contracts since 2024
$58M
1 awards · latest Dec 12, 2025

Federal contracts

$58,051,983 in federal contract awards across 1 actions since January 2024, most recently Dec 12, 2025. Amounts are obligated values as reported to USAspending; modifications and de-obligations can be negative.

By agency

  • Department of Health and Human Services$58M1 award

Largest awards

DateAwardAmount
Dec 12, 2025
Department of Health and Human Services
DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA
$58,051,983

Data: Quiver Quantitative, FEC, Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to Cidara Therapeutics, Inc. through its SEC registration (CIK 1610618) and tickers CDTX.

As of: contract actions through Dec 12, 2025. Snapshot rebuilt Sep 17, 2026.

Holdings values are estimates from disclosed ranges. Donation coverage for a cycle begins with the first month loaded, so earlier months may still be missing.